Medical Condition News RSS Feed - Medical Condition News

Recombinant human albumin from Novozymes Biopharma helps innovative dry eye therapy move into clinical trials

Recombinant human albumin from Novozymes Biopharma helps innovative dry eye therapy move into clinical trials

Novozymes Biopharma, part of Novozymes A/S world leader in bioinnovation, today announced that an ophthalmic solution made using its recombinant human albumin, has been approved for Phase I/II development by the FDA. [More]
FDA designates Synageva's sebelipase alfa as Breakthrough Therapy for early onset LAL Deficiency

FDA designates Synageva's sebelipase alfa as Breakthrough Therapy for early onset LAL Deficiency

Synageva BioPharma Corp., a biopharmaceutical company developing therapeutic products for rare diseases, today announced that the U.S. Food and Drug Administration granted Breakthrough Therapy designation to sebelipase alfa for the treatment of early onset lysosomal acid lipase deficiency, also known as Wolman disease. [More]
CEO Roundtable on Cancer accredits UW Medicine with CEO Cancer Gold Standard

CEO Roundtable on Cancer accredits UW Medicine with CEO Cancer Gold Standard

UW Medicine, a leading healthcare provider serving Seattle and the Northwest, is leading by example when it comes to promoting workplace wellness and encouraging healthier behavior. [More]
Researchers examine how BRD4 contributes to sustained presence of NF-kappa B in cancer cells

Researchers examine how BRD4 contributes to sustained presence of NF-kappa B in cancer cells

In a new study described in the journal Oncogene, researchers reveal how a key player in cell growth, immunity and the inflammatory response can be transformed into a primary contributor to tumor growth. [More]
GE Healthcare initiates global public awareness campaign on cancer prevention

GE Healthcare initiates global public awareness campaign on cancer prevention

GE Healthcare has today launched its third annual #GetFit global public awareness campaign on cancer prevention. This year's campaign leverages social media channels including Instagram, Sina Weibo in China, and Twitter to enable participation, interaction and engagement. [More]
Study shows people with SE-AN can be treated with outpatient treatment programme

Study shows people with SE-AN can be treated with outpatient treatment programme

Patients with the most severe and dangerous form of chronic anorexia are more likely to make a significant improvement towards recovery and stay in therapy if traditional psychological treatments are re-focused from weight gain to quality of life issues. [More]
XenoPort's Arbaclofen placarbil fails to meet co-primary endpoints in Phase 3 clinical trial

XenoPort's Arbaclofen placarbil fails to meet co-primary endpoints in Phase 3 clinical trial

XenoPort, Inc. announced today top-line results from its pivotal Phase 3 clinical trial of arbaclofen placarbil for the treatment of patients with spasticity due to multiple sclerosis. [More]

Novel medicine for chronic wound treatment

Every 20 seconds, a limb is lost as a consequence of diabetic foot ulcer that does not heal. To date, medical solutions that can change this situation are very limited. [More]
Cell Therapeutics announces issuance of final benefit assessment report for PIXUVRI

Cell Therapeutics announces issuance of final benefit assessment report for PIXUVRI

Cell Therapeutics, Inc. today reported that Germany's Federal Joint Committee has issued its final benefit assessment report for PIXUVRI (pixantrone), which is indicated as a monotherapy for the treatment of adult patients with aggressive B-cell non-Hodgkin lymphoma (NHL) who have failed two or three prior lines of therapy. [More]
AGA Research Foundation announces recipients of 2013 Student Research Fellowship Award

AGA Research Foundation announces recipients of 2013 Student Research Fellowship Award

The American Gastroenterological Association Research Foundation has announced the 2013 Student Research Fellowship Award recipients. The awards are intended to stimulate interest in research careers in digestive diseases among high school, undergraduate, graduate and medical school students. [More]
Measuring genetic diversity within tumor predicts outcomes of patients with head and neck cancer

Measuring genetic diversity within tumor predicts outcomes of patients with head and neck cancer

A new measure of the heterogeneity - the variety of genetic mutations - of cells within a tumor appears to predict treatment outcomes of patients with the most common type of head and neck cancer. [More]
Common foot disorders are inherited, says Framingham Foot Study

Common foot disorders are inherited, says Framingham Foot Study

A novel study reports that white men and women of European descent inherit common foot disorders, such as bunions (hallux valgus) and lesser toe deformities, including hammer or claw toe. [More]

Peripherally inserted central catheters increase risk of dangerous blood clots

Touted for safety, ease and patient convenience, peripherally inserted central catheters have become many clinicians' go-to for IV delivery of antibiotics, nutrition, chemotherapy, and other medications. [More]
Study shows treatment of sleep apnea in patients with prediabetes improves blood sugar levels

Study shows treatment of sleep apnea in patients with prediabetes improves blood sugar levels

Optimal treatment of sleep apnea in patients with prediabetes improves blood sugar (glucose) levels and thus can reduce cardiometabolic risk, according to a study to be presented at the ATS 2013 International Conference in Philadelphia. [More]

Purified components of ginger help asthma patients breathe more easily

Gourmands and foodies everywhere have long recognized ginger as a great way to add a little peppery zing to both sweet and savory dishes; now, a study from researchers at Columbia University shows purified components of the spicy root also may have properties that help asthma patients breathe more easily. [More]
Targeting glucagon action: A new frontier for regulating diabetes

Targeting glucagon action: A new frontier for regulating diabetes

For the first time, scientists at the Toronto General Research Institute showed that targeting glucagon action in the brain may be a new frontier for regulating diabetes. [More]
Promising method to distinguish pancreatic cancer from chronic pancreatitis

Promising method to distinguish pancreatic cancer from chronic pancreatitis

Researchers at Mayo Clinic have developed a promising method to distinguish between pancreatic cancer and chronic pancreatitis - two disorders that are difficult to tell apart. A molecular marker obtained from pancreatic "juices" can identify almost all cases of pancreatic cancer, their study shows. [More]

Joint replacement surgery might be avoidable in the future, suggest scientists

Scientists at Johns Hopkins have turned their view of osteoarthritis inside out. Literally. Instead of seeing the painful degenerative disease as a problem primarily of the cartilage that cushions joints, they now have evidence that the bone underneath the cartilage is also a key player and exacerbates the damage. [More]

AGA Research Foundation announces 2013 research scholars

The American Gastroenterological Association Research Foundation is pleased to announce its 2013 research scholars. This year's honorees are outstanding young gastroenterologists working toward independent careers in gastroenterology, hepatology or related areas, and with this award, their research time will be protected. [More]
New computational method may help track tumor progression, risk of relapse

New computational method may help track tumor progression, risk of relapse

In their quest to learn more about the variability of cells between and within tissues, biomedical scientists have devised tools capable of simultaneously measuring dozens of characteristics of individual cells. These technologies have led to new challenges, however, as scientists now struggle with how to make sense of the resulting trove of data. Now a solution may be at hand. [More]